Rahman, Razia
Rahaman, Muhammed H.
Hanson, Adrienne R.
Choo, Nicholas
Xie, Jianling http://orcid.org/0000-0002-0588-8016
Townley, Scott L.
Shrestha, Raj
Hassankhani, Ramin
Islam, Saiful
Ramm, Susanne
Simpson, Kaylene J.
Risbridger, Gail P. http://orcid.org/0000-0003-3089-4028
Best, Giles
Centenera, Margaret M.
Balk, Steven P. http://orcid.org/0000-0002-4546-7371
Kichenadasse, Ganessan http://orcid.org/0000-0001-9923-5149
Taylor, Renea A.
Butler, Lisa M. http://orcid.org/0000-0003-2698-3220
Tilley, Wayne D. http://orcid.org/0000-0003-1893-2626
Conn, Simon J. http://orcid.org/0000-0002-1376-4515
Lawrence, Mitchell G.
Wang, Shudong
Selth, Luke A. http://orcid.org/0000-0002-4686-1418
Funding for this research was provided by:
Hospital Research Foundation (C-PJ-126-2019, C-PJ-126-2019, C-PJ-126-2019)
Cancer Australia (2001432, 2001432, 2001432, 2001432)
National Breast Cancer Foundation (MNBCF-17-012, MNBCF-17-012)
Movember Foundation (MNBCF-17-012, MNBCF-17-012, MNBCF-17-012)
Cancer Council South Australia (PRF2919, PRF1117)
Australian Cancer Research Foundation
U.S. Department of Health & Human Services | National Institutes of Health (P01 CA1163227)
Victorian Cancer Agency (MCRF15023, MCRF18017)
Article History
Received: 26 October 2023
Revised: 18 July 2024
Accepted: 25 July 2024
First Online: 8 August 2024
Competing interests
: G Risbridger, R Taylor and M Lawrence (Research collaborations: AstraZeneca, Pfizer, Astellas, Zenith Epigenetics for research on compounds not associated with this study).